StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.50−0.06 (-3.85%)

Close on Nov 17, 2026Market cap $33.05MP/E –Yield –

Nexalin Technology, Inc. grew revenue 24.2% to $217.16K over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $33.05M.

Revenue
$217.16K
+24.2% vs. a year earlier
Operating income
-$9.13M
TTM Q2 2026
EPS, diluted
-$0.48
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$33.05M
P/E ratio
–
Price to sales
152.22
Price to book
21.75
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$217.16K
Net income
-$8.99M
EPS, diluted
-$0.48
Book value per share
$0.07
Diluted shares
21M

Trading

Previous close
$1.56
Open
$1.59
Day's range
$1.47 – $1.60
Volume
6,966
Average volume (20 days)
28,301
52-week range
$1.31 – $33.60
RSI (14 days)
31.6
Volatility (1 year)
131.5%
Relative volume
0.01×

Market cap history

Month-end market cap since 2022, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.

PeriodNXLS&P 500DifferenceNXL per yearS&P 500 per year
1 month-36.2%-4.0%−32.1 pts
3 months-85.3%-5.0%−80.3 pts
Year to date-91.0%+8.2%−99.3 pts
1 year-95.4%+11.2%−106.6 pts
3 years-83.6%+68.5%−152.0 pts-45.2%+19.0%

Six years at a glance

Fiscal years 2020 to 2025 and trailing twelve months, USD

Revenue

$217.16K+24.2% YoY

Gross profit

$187.10K+58.3% YoY

Operating income

-$9.13M

Net income

-$8.99M

EPS, diluted

-$0.48
Reported periodTrailing twelve months

Press releases

Releases Nexalin Technology filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Nexalin Technology

Electromedical & Electrotherapeutic Apparatus

Nexalin designs and creates bioelectronic neurostimulation medical devices designed to address mental health conditions including anxiety, depression, and insomnia without pharmaceutical drugs or psychotherapy. Its core technology utilizes non-invasive electrical waveforms emitted through patient headsets and clinical systems. Offerings include its original Generation 1 cranial electrotherapy stimulation unit, alongside its advanced Generation 2 SYNC clinical console and Generation 3 HALO at-home headset systems. The company also supplies single-use radio-frequency identification electrodes, patient cables, and related licensing services. Customers comprise healthcare providers and licensed medical professionals who administer treatments in clinics or prescribe devices for home use via virtual clinic platforms.

Company profile, executives and history

Nexalin Technology stock: common questions

What is Nexalin Technology's stock price?

NXL closed at $1.50 on Nov 17, 2026, down 3.85% on the day. Over the past 52 weeks it traded between $1.31 and $33.60.

What is Nexalin Technology's market cap?

Nexalin Technology was worth $33.05M at the close on Nov 17, 2026: the share price times the diluted shares outstanding.

What is NXL's P/E ratio?

Nexalin Technology lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.48), so it has no meaningful P/E ratio.

How much revenue does Nexalin Technology make?

Nexalin Technology reported revenue of $217.16K for the twelve months to Jun 30, 2026, up 24.2% from a year earlier.

Does Nexalin Technology pay a dividend?

No. Nexalin Technology has not paid a cash dividend over the last twelve months.

How has NXL stock performed over the past year?

Including dividends, NXL returned -95.4% over the past year, against +11.2% for the S&P 500.

How many NXL shares are sold short?

0M shares were sold short at the latest FINRA report, 0.07% of the float, or 1.0 days of average trading volume.

Who are Nexalin Technology's competitors?

Companies most similar to Nexalin Technology by business, industry and size include ITOC, POSC, GTHP, COCH, QTEX.

See a number that looks wrong?